Shareholders of Allscripts-Misys Healthcare Solutions and Eclipsys Corp. today approved a $1.3 billion deal to merge the two companies, according to Allscripts and Eclipsys. In both cases, 99% of the shareholders approved of the deal, the plans for which were announced June 9. For Atlanta-based Eclipsys, those shares represented 83% of the total shares eligible to vote.
Allscripts, Eclipsys shareholders OK merger
To complete the deal, Chicago-based Allscripts must buy out shares owned by Misys, a British company that took a majority stake in Allscripts in a 2008 deal that combined its Misys Healthcare Systems unit with Allscripts.
Allscripts CEO Glen Tullman will lead the company after the merger. Tullman discussed the Eclipsys deal in a video news report with Modern Healthcare reporter Andis Robeznieks in June.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.